Diabetech - Diabetes Tech, Research, News The Future of Insulin Pumps: Inside the Next-Gen Pump Wars
Nov 17, 2025
Dr. David Ahn, chief of diabetes services at the Mary and Dick Allen Diabetes Center, explores the future of insulin pumps. He discusses the competitive landscape between companies like Omnipod and Tandem, the importance of seven-day wearable infusion sets, and the evolving algorithms for insulin delivery. Ahn highlights the potential for dual-hormone systems and addresses the future of closed-loop systems. The conversation delves into innovations like Beta Bionics' reusable Mint pump and the need for more user-friendly technology in diabetes management.
AI Snips
Chapters
Transcript
Episode notes
Why Tubeless Became Dominant
- Tubeless pumps won by removing tubing's medical stigma and making devices more approachable for new users.
- People prefer tubeless because it feels less intrusive, more discreet, and easier to forget it's worn.
What Omnipod Needs Next
- Omnipod should focus on a smaller form factor, longer wear, and algorithm improvements to stay competitive.
- Upgrading targets and adding auto‑correction boluses would materially improve Omnipod's competitiveness.
Use Longer Set Lives To Improve Connectivity
- Favor longer infusion-set wear to reduce site/sensor scheduling conflicts and improve connectivity time near your CGM.
- Seek infusion sites that overlap sensor life to lower signal-loss and setup hassle.